Y-MABS THERAPEUTICS INC shareholders Q3 2023

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
XTX Topco Ltd 31,690$172,7110.03%
ACADIAN ASSET MANAGEMENT LLC 811,261$4,4200.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 530,439$2,890,8930.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 40,960$223,2320.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,600$521,0200.01%
Trexquant Investment LP 76,585$417,3880.01%
Avestar Capital, LLC 10,000$54,5000.01%
D. E. Shaw & Co., Inc. 1,349,210$7,353,1950.01%
ALGERT GLOBAL LLC 26,670$1450.01%
LOS ANGELES CAPITAL MANAGEMENT LLC 303,920$1,656,3640.01%
External links

This page lists Y-MABS THERAPEUTICS INC's shareholders in Q3 2023. To view Y-MABS THERAPEUTICS INC's shareholder history, click here.